Therefore, several ongoing efforts in this field are aimed at blocking TGF-β in the stroma in combination with anti-programmed death (PD)-1 immunotherapy for the treatment of different cancer types, including pancreatic cancer [31]. The gene discussed is TGFB1; the disease is pancreatic neoplasm.